SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-19-075593
Filing Date
2019-12-23
Accepted
2019-12-23 16:15:16
Documents
1
Group Members
SAGARD CAPITAL PARTNERS GP, INC.SAGARD CAPITAL PARTNERS MANAGEMENT CORP.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a19-26835_1sc13da.htm SC 13D/A 91873
  Complete submission text file 0001104659-19-075593.txt   93567
Mailing Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017
Business Address 280 PARK AVENUE, 3RD FLOOR WEST NEW YORK NY 10017 203 629-6700
Sagard Capital Partners, L.P. (Filed by) CIK: 0001423385 (see all company filings)

IRS No.: 203332164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Subject) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88872 | Film No.: 191306217
SIC: 2834 Pharmaceutical Preparations